Directory Last Updated: 20 November 2024
Return to Directory Key Opinion Leaders in Clinical Trials Areas - word selected:- LYMPHOPROLIFERATIVE
Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs.
Page No 1
PhraseConsultantTownSpecial Interests
lymphoproliferative disease
*Consultant(s)*
*Towns*Lymphoma, lymphoproliferative disease, stem cell transplant, chronic lymphocytic leukaemia, general haematology
Lymphoproliferative disease
*Consultant(s)*
*Towns*Lymphoproliferative disease
lymphoproliferative disease
*Consultant(s)*
*Towns*Paediatric oncology, leukaemia and lymphoma and late effects, lymphoproliferative disease
lymphoproliferative diseases
*Consultant(s)*
*Towns*Haematological oncology, lymphoproliferative diseases, acute lymphoblastic leukaemia
lymphoproliferative disorders
*Consultant(s)*
*Towns*Medical oncology, lymphoma, high dose chemotherapy with stem cell support, HIV associated malignancy, lymphoproliferative disorders
Page No 1
Spacer

Third Party Advertisement

Adverts by Google